Fenofibrate (GMP)

Overview

Fenofibrate (GMP) is Fenofibrate ( HY-17356 ) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Fenofibrate is a selective PPARα agonist with an EC 50 of 30 μM. Fenofibrate also inhibits human cytochrome P450 isoforms, with IC 50 s of 0.2, 0.7, 9.7, 4.8 and 142.1 μM for CYP2C19 , CYP2B6 , CYP2C9 , CYP2C8 , and CYP3A4 , respectively.

Application

Products | Products > GMP Small Molecules | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-17356G
• CAS No.: 49562-28-9
• Molecular Formula: C20H21ClO4
• Molecular Weight: 360.83
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source